C
The startup specializes in developing proprietary formulations for specialty pharmaceuticals targeting bone health, immunity, and respiratory conditions. By optimizing therapy outcomes, the company enables patients in underserved markets to access effective treatments that are tailored to their specific health needs.
Louvain-la-Neuve, Belgium
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup specializes in developing proprietary formulations for specialty pharmaceuticals targeting bone health, immunity, and respiratory conditions. By optimizing therapy outcomes, the company enables patients in underserved markets to access effective treatments that are tailored to their specific health needs.